Company Filing History:
Years Active: 2025
Title: Innovations by Matthew Chang in Cancer Research
Introduction
Matthew Chang is an accomplished inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer research, particularly through his work on antibodies targeting MUC1, a protein that is overexpressed in various cancers.
Latest Patents
Matthew Chang holds a patent for "Antibodies against MUC1." This invention focuses on the discovery of monoclonal antibodies and fragments, such as a human single chain variable fragment (scFv), that specifically recognize human MUC1-SEA. His innovative approach aims to enhance the detection and treatment of cancers affecting the lung, colon, breast, ovary, and pancreas. He has 1 patent to his name.
Career Highlights
Matthew Chang is affiliated with the Dana-Farber Cancer Institute Inc., where he collaborates with leading experts in the field. His work has been instrumental in advancing the understanding of cancer biology and developing targeted therapies.
Collaborations
He has worked alongside notable colleagues, including Wayne A. Marasco and Elizabeth Baez, contributing to a collaborative environment that fosters innovation and research excellence.
Conclusion
Matthew Chang's contributions to cancer research through his innovative patents and collaborations highlight his commitment to improving cancer treatment and detection. His work continues to inspire advancements in the medical field.